In a recent study published in the November issue of The Journal of Clinical Pharmacology, researchers from Pfizer Global Research and Development report on the first clinical trial studying the safety, tolerability, and pharmacokinetics of the drug varenicline on 65 to 75 year-old smokers.
A research team has identified a key enzyme responsible for triggering a chain of events that results in allergic reaction, according to new study findings published online this week in Nature Immunology.
More than 39 million Americans know the value of a respiratory therapist. According to the American Association for Respiratory Care, that is how many people suffer from lung disease. This week—the 25th annual National Respiratory Care Week—shines the spotlight on respiratory therapists and brings awareness to a growing shortage in the field.
Statins, the widely used class of drugs for cholesterol management, are now showing promising results in slowing smoking-induced lung damage.
Australian researchers have found that exposure to measured doses of ultraviolet light, such as sunlight, could reduce asthma.
SeQual Technologies Inc, San Diego, announced today that health providers nationwide will now be reimbursed by Medicare for the portable portion of their use of SeQual’s Eclipse Oxygen System. Prior to the decision by the Centers for Medicare & Medicaid Services (CMS), providers could only bill Medicare for the Eclipse’s use as a stationary concentrator.
Ingen Technologies Inc, Yucaipa, Calif, a medical device manufacturer and research developer of medical technologies, has begun production of its medical device, OxyView™.
One-quarter of long-term smokers are likely to develop chronic obstructive pulmonary disease (COPD), according to Danish researchers.
University of Texas (UT) Southwestern Medical Center is one of a handful of top research institutions evaluating a promising new medication that researchers hope can reduce the severity and frequency of asthma attacks in inner-city children, a population known to have a high prevalence of severe asthma.
Virginia Commonwealth University (VCU) researchers have identified how a bioactive molecule involved with allergy, inflammation, and cancer is transported out of mast cells, according to findings published online this week in the Proceedings of the National Academy of Sciences.